On October 6, 2023, the Drug Enforcement Administration (DEA) released a second temporary rule extending the COVID-19 Telemedicine Flexibilities for Prescription of Controlled.
DEA Extends Coronavirus Telehealth Prescription Rules natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
DEA indicates along with SAMHSA that it will review comments received in response to the March 2023 Proposed Rules, conduct a thorough evaluation of regulatory alternatives, and issue one or more final rules based on the March 2023 Proposed Rules prior to 11 November 2023
The Drug Enforcement Agency released Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. They have extended COVID-19 waivers for prescribing controlled substances via telemedicine until November 11, 2023.